PRISM BioLab Co

PRISM BioLab Co Dividend

Dividend of PRISM BioLab Co (206A.T) as of Nov 22, 2026.

Dividend

0.00JPY

Last updated:

How much dividend does PRISM BioLab Co 2026 pay?

According to the latest status from November 2026, PRISM BioLab Co paid a total of 0.00 JPY per share in dividends within the last 12 months. With the current PRISM BioLab Co price of 82.00 JPY, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical PRISM BioLab Co Dividends

Historical PRISM BioLab Co Dividends
PaydateDividend

The PRISM BioLab Co Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2022
0.00 JPY
Jan 1, 2023
0.00 JPY
Jan 1, 2024
0.00 JPY
Jan 1, 2025
0.00 JPY
Jan 1, 2026 (e)
0.00 JPY
The PRISM BioLab Co Dividend history
YEARDividendYoY
est0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—
0.00JPY—

Is the PRISM BioLab Co Dividend Safe?

PRISM BioLab Co has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding PRISM BioLab Co's Dividend Distributions

PRISM BioLab Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining PRISM BioLab Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

PRISM BioLab Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in PRISM BioLab Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

PRISM BioLab Co Stock analysis

What does PRISM BioLab Co do? PRISM BioLab Co Ltd generates revenue through two distinct business models in the pharmaceuticals sector. The in-house development business focuses on selecting drug discovery targets and creating programs internally using their PepMetics technology platform. The joint development business collaborates with pharmaceutical companies to develop drug discovery programs leveraging their proprietary PepMetics technology. Both models utilize the company's owned drug discovery platform to create new pharmaceutical products. The company's primary clients are pharmaceutical companies seeking to develop new drugs through partnerships with PRISM BioLab's technology. PRISM BioLab's business model centers on its PepMetics technology, which serves as the foundation for both its in-house development and joint development segments. The company builds new drug discovery platforms and develops new drugs through these segments, targeting pharmaceutical companies as their main customers. The firm's research and development activities are conducted using their owned technology, which differentiates their approach in the drug discovery market. The company's revenue streams are derived from pharmaceutical companies that partner with PRISM BioLab for drug discovery programs. By utilizing their PepMetics technology platform, the company creates targeted drug discovery solutions that are developed either internally or in collaboration with pharmaceutical partners. This approach allows PRISM BioLab to generate income through both direct development efforts and collaborative projects with industry clients. PRISM BioLab Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PRISM BioLab Co stock

PRISM BioLab Co paid dividends every year for the past 0 years.

PRISM BioLab Co is assigned to the 'Health' sector.

The dividends of PRISM BioLab Co are distributed in JPY.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — PRISM BioLab Co